Global IVUS-OCT Market Growth 2026-2032
Description
The global IVUS-OCT market size is predicted to grow from US$ 30.87 million in 2025 to US$ 125 million in 2032; it is expected to grow at a CAGR of 20.6% from 2026 to 2032.
IVUS-OCT is a medical device that combines intravascular ultrasound imaging (IVUS) and optical coherence tomography (OCT) for image acquisition and diagnosis within blood vessels.
IVUS and OCT are two commonly used vascular imaging techniques that provide high-resolution images of vascular structure and dynamic data, helping physicians assess vascular lesions, the degree of stenosis, and procedures such as stent placement. Combining IVUS and OCT in a single device allows for the simultaneous acquisition of the advantages of both imaging modalities, providing a more comprehensive vascular assessment and diagnostic capability.
On the supply side, global production is highly concentrated in China and the United States, with no meaningful output from other regions through 2031. In the initial commercialization phase, U.S. output accounted for 100% of production value and units in 2020–2021, but from 2022 onward Chinese manufacturing rapidly became dominant as Panovision and other domestic hybrid IVUS-OCT platforms moved from registration into scaled deployment. By 2025, China contributed over 90% of global production value and units, while the U.S. share fell to mid-single digits. Looking forward, the model assumes that U.S. and other ex-China roll-outs accelerate from 2026, so that by 2031 China still retains roughly two-thirds of global production value and volume, but the U.S. share rises to around one-third, and “Rest of World” remains marginal.
The competitive landscape is narrow and technology-intensive. Over the historical window 2020–2025, essentially all commercial production is attributed to six manufacturers: Conavi Medical Inc (Canada), Grand Pharmaceutical, Panovision, Terumo, Horimed Technology Co., Ltd and InnerMedical Co., Ltd. The Chinese players collectively dominate global unit output and production value, leveraging local manufacturing, regulatory approval by NMPA and bundling strategies in high-value consumable tenders, while Conavi and Terumo act as the leading non-Chinese innovators with footprints in North America, Japan and selected international markets. Market share tables and price curves for 2020–2025 confirm a highly concentrated structure with limited new entrants and no meaningful contribution from general imaging OEMs or catheter OEMs without their own console platforms.
Overall, the research supports a conclusion that hybrid IVUS-OCT will remain a fast-growing but structurally niche segment of the global cardiovascular device market through 2031. The technology will be concentrated in high-volume cath labs and complex PCI centers, with China and the U.S./Canada accounting for the vast majority of installations and revenue, and a small group of specialized manufacturers capturing most of the value.
LP Information, Inc. (LPI) ' newest research report, the “IVUS-OCT Industry Forecast” looks at past sales and reviews total world IVUS-OCT sales in 2025, providing a comprehensive analysis by region and market sector of projected IVUS-OCT sales for 2026 through 2032. With IVUS-OCT sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVUS-OCT industry.
This Insight Report provides a comprehensive analysis of the global IVUS-OCT landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVUS-OCT portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVUS-OCT market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVUS-OCT and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVUS-OCT.
This report presents a comprehensive overview, market shares, and growth opportunities of IVUS-OCT market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
36 mm/s Retraction Speed
25 mm/s Retraction Speed
10 mm/s Retraction Speed
Others
Segmentation by Application:
Public Hospitals
Private Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Panovision Medical
Conavi Medical
Grand Pharmaceutical
Horimed Care
Terumo
InnerMedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global IVUS-OCT market?
What factors are driving IVUS-OCT market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVUS-OCT market opportunities vary by end market size?
How does IVUS-OCT break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
IVUS-OCT is a medical device that combines intravascular ultrasound imaging (IVUS) and optical coherence tomography (OCT) for image acquisition and diagnosis within blood vessels.
IVUS and OCT are two commonly used vascular imaging techniques that provide high-resolution images of vascular structure and dynamic data, helping physicians assess vascular lesions, the degree of stenosis, and procedures such as stent placement. Combining IVUS and OCT in a single device allows for the simultaneous acquisition of the advantages of both imaging modalities, providing a more comprehensive vascular assessment and diagnostic capability.
On the supply side, global production is highly concentrated in China and the United States, with no meaningful output from other regions through 2031. In the initial commercialization phase, U.S. output accounted for 100% of production value and units in 2020–2021, but from 2022 onward Chinese manufacturing rapidly became dominant as Panovision and other domestic hybrid IVUS-OCT platforms moved from registration into scaled deployment. By 2025, China contributed over 90% of global production value and units, while the U.S. share fell to mid-single digits. Looking forward, the model assumes that U.S. and other ex-China roll-outs accelerate from 2026, so that by 2031 China still retains roughly two-thirds of global production value and volume, but the U.S. share rises to around one-third, and “Rest of World” remains marginal.
The competitive landscape is narrow and technology-intensive. Over the historical window 2020–2025, essentially all commercial production is attributed to six manufacturers: Conavi Medical Inc (Canada), Grand Pharmaceutical, Panovision, Terumo, Horimed Technology Co., Ltd and InnerMedical Co., Ltd. The Chinese players collectively dominate global unit output and production value, leveraging local manufacturing, regulatory approval by NMPA and bundling strategies in high-value consumable tenders, while Conavi and Terumo act as the leading non-Chinese innovators with footprints in North America, Japan and selected international markets. Market share tables and price curves for 2020–2025 confirm a highly concentrated structure with limited new entrants and no meaningful contribution from general imaging OEMs or catheter OEMs without their own console platforms.
Overall, the research supports a conclusion that hybrid IVUS-OCT will remain a fast-growing but structurally niche segment of the global cardiovascular device market through 2031. The technology will be concentrated in high-volume cath labs and complex PCI centers, with China and the U.S./Canada accounting for the vast majority of installations and revenue, and a small group of specialized manufacturers capturing most of the value.
LP Information, Inc. (LPI) ' newest research report, the “IVUS-OCT Industry Forecast” looks at past sales and reviews total world IVUS-OCT sales in 2025, providing a comprehensive analysis by region and market sector of projected IVUS-OCT sales for 2026 through 2032. With IVUS-OCT sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVUS-OCT industry.
This Insight Report provides a comprehensive analysis of the global IVUS-OCT landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVUS-OCT portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVUS-OCT market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVUS-OCT and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVUS-OCT.
This report presents a comprehensive overview, market shares, and growth opportunities of IVUS-OCT market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
36 mm/s Retraction Speed
25 mm/s Retraction Speed
10 mm/s Retraction Speed
Others
Segmentation by Application:
Public Hospitals
Private Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Panovision Medical
Conavi Medical
Grand Pharmaceutical
Horimed Care
Terumo
InnerMedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global IVUS-OCT market?
What factors are driving IVUS-OCT market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVUS-OCT market opportunities vary by end market size?
How does IVUS-OCT break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
91 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for IVUS-OCT by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for IVUS-OCT by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
